Vaxneuvance Europska Unija - hrvatski - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumococcal infekcije - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. pogledajte odjeljke 4. 4 i 5. 1 za informacije o zaštiti od specifičnih pneumokoknih serotipova. the use of vaxneuvance should be in accordance with official recommendations.

Nimenrix Europska Unija - hrvatski - EMA (European Medicines Agency)

nimenrix

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningitis, meningokokal - cjepiva - nimenrix je indiciran za aktivnu imunizaciju osoba od dobi od 6 tjedana protiv invazivnih meningokoknih bolesti uzrokovanih neisseria meningitidis grupom a, c, w-135 i y.

SPRAY NASAL Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

spray nasal

medikor d.o.o., zagreb - fiziološka otopina morske vode za svakodnevnu njegu nosa

BioBos Respi 2 intranasal Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

biobos respi 2 intranasal

vet consulting d.o.o., matije gupca 42, 43500 daruvar - atenuirani virus parainfluence goveda tip 3 (pi3v), soj bio 23/a; atenuirani respiratorni sincicijski virus goveda (brsv), soj bio 24/a - sprej za nos, liofilizat i otapalo za suspenziju - imunološki pripravci za goveda, živa virusna cjepiva - goveda

BioBos Respi 2 intranasal Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

biobos respi 2 intranasal

bioveta, a.s., komenského 212/12, 683 23 ivanovice na hané, republika Češka - atenuirani virus parainfluence goveda tip 3 (pi3v), soj bio 23/a; atenuirani respiratorni sincicijski virus goveda (brsv), soj bio 24/a - sprej za nos, liofilizat i otapalo za suspenziju - imunološki pripravci za goveda, živa virusna cjepiva - goveda

Bovilis INtranasal RSP Live Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

bovilis intranasal rsp live

intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb - 1. živi respiratorni sincicijski virus goveda; (engl. bovine respiratory syncytial virus - brsv), soj jencine-2013; 2. živi virus parainfluence goveda, tip 3; (engl. bovine parainfluenza virus type 3 - pi3), soj int2-2013 - sprej za nos, liofilizat i otapalo za suspenziju - goveda

Heplisav B Europska Unija - hrvatski - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - hepatitis b površinski antigen - hepatitis b - cjepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Apexxnar Europska Unija - hrvatski - EMA (European Medicines Agency)

apexxnar

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumococcal infekcije - cjepiva - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. pogledajte odjeljke 4. 4 i 5. 1 za informacije o zaštiti od specifičnih pneumokoknih serotipova. apexxnar should be used in accordance with official recommendations. .

Enzepi Europska Unija - hrvatski - EMA (European Medicines Agency)

enzepi

allergan pharmaceuticals international ltd - gušterača u prahu - nedostatnost egzocrvene gušterače - probavite, uklj. enzimi - gušterače enzim zamjena tretman u exocrine gušterače insuficijencija zbog cistične fibroze ili drugim uvjetima (e. kronični pankreatitis, post-pancreatectomy ili karcinom gušterače). enzepi drugačije u bebe, djecu, mlade i odrasle.